BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9323143)

  • 1. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.
    Lavertu P; Adelstein DJ; Saxton JP; Secic M; Wanamaker JR; Eliachar I; Wood BG; Strome M
    Head Neck; 1997 Oct; 19(7):559-66. PubMed ID: 9323143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.
    Adelstein DJ; Saxton JP; Lavertu P; Tuason L; Wood BG; Wanamaker JR; Eliachar I; Strome M; Van Kirk MA
    Head Neck; 1997 Oct; 19(7):567-75. PubMed ID: 9323144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
    Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
    Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Adelstein DJ; Lavertu P; Saxton JP; Secic M; Wood BG; Wanamaker JR; Eliachar I; Strome M; Larto MA
    Cancer; 2000 Feb; 88(4):876-83. PubMed ID: 10679658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Watch-and-see" policy for the clinically positive neck in head and neck cancer treated with chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Suzuki F; Higuchi E; Nishioka T; Shirato H; Nagahashi T; Yagi K; Fukuda S
    Int J Clin Oncol; 2006 Dec; 11(6):441-8. PubMed ID: 17180512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation.
    Wolf GT; Fisher SG
    Laryngoscope; 1992 Aug; 102(8):934-9. PubMed ID: 1495357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.
    Lavertu P; Bonafede JP; Adelstein DJ; Saxton JP; Strome M; Wanamaker JR; Eliachar I; Wood BG
    Arch Otolaryngol Head Neck Surg; 1998 Apr; 124(4):401-6. PubMed ID: 9559686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer.
    Sanguineti G; Corvo R; Benasso M; Margarino G; Sormani M; Roncallo F; Mereu P; Bacigalupo A; Vitale V
    Head Neck; 1999 May; 21(3):223-8. PubMed ID: 10208665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
    Lau H; Phan T; Mackinnon J; Matthews TW
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy.
    Thomas GR; Greenberg J; Wu KT; Moe K; Esclamado R; Bradford C; Carroll W; Eisbruch A; Urba S; Wolf GT
    Laryngoscope; 1997 Aug; 107(8):1129-37. PubMed ID: 9261021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of chemotherapy and radiotherapy in sterilizing cervical nodal disease in squamous cell carcinoma of the head and neck.
    Moore MG; Bhattacharyya N
    Laryngoscope; 2005 Apr; 115(4):570-3. PubMed ID: 15805860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy pf cervical lymph node metastases of unknown primary tumor].
    Kirschner MJ; Fietkau R; Waldfahrer F; Iro H; Sauer R
    Strahlenther Onkol; 1997 Jul; 173(7):362-8. PubMed ID: 9265258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.